Sunil Kannanganat Sidharthan
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$6.1MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $6.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 11, 2026 | NIH | SBIR Phase I Severe Autoantibody-Mediated Autoimmune Disease: A New Treatment Approach | $306K | ASTERO ERADO INC |
| May 19, 2026 | NIH | SBIR Phase II Novel approaches for the treatment of autoimmune disease | $1.0M | ASTERO ERADO INC |
| Jun 17, 2025 | NIH | SBIR Phase II Depleting autoantibodies for the treatment of autoimmunity | $863K | ASTERO ERADO INC |
| Apr 22, 2025 | NIH | SBIR Phase II Novel approaches for the treatment of autoimmune disease | $1.0M | ASTERO ERADO INC |
| Jun 26, 2024 | NIH | SBIR Phase I Novel treatments for Autoimmune Disease | $293K | ASTERO ERADO INC |
| Mar 7, 2024 | NIH | SBIR Phase II Depleting autoantibodies for the treatment of autoimmunity | $1.0M | ASTERO ERADO INC |
| Jun 1, 2023 | NIH | SBIR Phase I Novel treatments for Autoimmune Disease | $305K | ASTERO ERADO INC |
| Mar 23, 2023 | NIH | SBIR Phase II Depleting autoantibodies for the treatment of autoimmunity | $1.0M | ASTERO ERADO INC |
| Dec 15, 2022 | NIH | SBIR Phase I Novel approaches for the treatment of autoimmune disease | $275K | ASTERO ERADO INC |
Peer ranks
Federal funding#179
Awards as PI#151
Patents#273
Companies
- ASTERO ERADO INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.